Jie Gu

3PUBLICATIONS
12CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 22, 2026
Targeting IRF1-TRIM21 axis enhances anti-tumor immunity by promoting ubiquitin-mediated degradation of FGL1 in non-small cell lung cancer.

|May 19, 2025
Intra-tumoural RAMP1+ B cells promote resistance to neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma.

Hongyu Zhang, Yuchen Zhang, Pingjing Zhou

|Oct 01, 2024
Gram-Negative Microflora Dysbiosis Facilitates Tumor Progression and Immune Evasion by Activating the CCL3/CCL5-CCR1-MAPK-PD-L1 Pathway in Esophageal Squamous Cell Carcinoma.

Huiqin Yang, Jiahao Cai, Xiaolong Huang

Pageof 1

Frequent Collaborators

2 joint publications

Huiqin Yang

1 joint publications

Jiahao Cai

1 joint publications

Xiaolong Huang

1 joint publications

Cheng Zhan